The human immune system serves as our body’s defense against harmful pathogens and cancer by identifying and eliminating abnormal cells. To maintain immune homeostasis several mechanisms are employed, which involve a wide range of proteins, including the Casitas B lymphoma-b (Cbl-b) protein, present in various immune cells. Cbl-b helps modulate immune responses by downregulating the activity of multiple immune cells. This inhibitory effect is significant in cancer development and progression as it promotes an immunosuppressive tumor environment.
Cheryl Arrowsmith, Chief Scientist of the Structural Genomics Consortium (SGC), Senior Scientist at the Princess Margaret Cancer Centre, and Professor at the Department of Medical Biophysics at the University of Toronto, has been recognized by UBC Medicine for her exceptional contributions to cancer research.
We are thrilled to share the news that Dr. Rachel Harding, Principal Investigator at the SGC-Toronto, has taken on the role of Assistant Professor in the Department of Pharmaceutical Sciences at the Leslie Dan Faculty of Pharmacy, University of Toronto.